160 related articles for article (PubMed ID: 8783400)
41. ARCON: a novel biology-based approach in radiotherapy.
Kaanders JH; Bussink J; van der Kogel AJ
Lancet Oncol; 2002 Dec; 3(12):728-37. PubMed ID: 12473514
[TBL] [Abstract][Full Text] [Related]
42. Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
Rojas A; Stratford MR; Bentzen SM; Denekamp J
Int J Radiat Biol; 2004 Jul; 80(7):499-506. PubMed ID: 15360088
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
[TBL] [Abstract][Full Text] [Related]
44. Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance.
Haustermans K; van der Kogel AJ; Vanacker B; van der Schueren E
Radiother Oncol; 1994 May; 31(2):123-8. PubMed ID: 8066191
[TBL] [Abstract][Full Text] [Related]
45. Improvement of tumor oxygenation by mild hyperthermia.
Song CW; Park H; Griffin RJ
Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
Bussink J; Kaanders JH; Van der Kogel AJ
Acta Oncol; 1999; 38(7):875-82. PubMed ID: 10606417
[TBL] [Abstract][Full Text] [Related]
47. ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
Bernier J; Denekamp J; Rojas A; Trovò M; Horiot JC; Hamers H; Antognoni P; Dahl O; Richaud P; Kaanders J; van Glabbeke M; Piérart M
Radiother Oncol; 1999 Aug; 52(2):149-56. PubMed ID: 10577700
[TBL] [Abstract][Full Text] [Related]
48. Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.
Gupta N; Saleem A; Kötz B; Osman S; Aboagye EO; Phillips R; Vernon C; Wasan H; Jones T; Hoskin PJ; Price PM
Clin Cancer Res; 2006 May; 12(10):3115-23. PubMed ID: 16707610
[TBL] [Abstract][Full Text] [Related]
49. Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.
Laurence VM; Ward R; Dennis IF; Bleehen NM
Br J Cancer; 1995 Jul; 72(1):198-205. PubMed ID: 7599052
[TBL] [Abstract][Full Text] [Related]
50. Tumor oxygenation and radiosensitization by pentoxifylline and a perflubron emulsion carbogen breathing.
Teicher B; Sotomayor E; Robinson M; Dupuis N; Schwartz G; Frei E
Int J Oncol; 1993 Jan; 2(1):13-21. PubMed ID: 21573510
[TBL] [Abstract][Full Text] [Related]
51. Modulation of hypoxia in murine liver metastases of colon carcinoma by nicotinamide and carbogen.
van Laarhoven HW; Bussink J; Lok J; Verhagen I; Punt CJ; Heerschap A; Kaanders JH; van der Kogel AJ
Radiat Res; 2005 Sep; 164(3):245-9. PubMed ID: 16137196
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
Rojas A; Hodgkiss RJ; Stratford MR; Dennis MF; Johns H
Br J Cancer; 1993 Dec; 68(6):1115-21. PubMed ID: 8260362
[TBL] [Abstract][Full Text] [Related]
53. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
Martin DF; Porter EA; Fischer JJ; Rockwell S
Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
[TBL] [Abstract][Full Text] [Related]
54. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
[No Abstract] [Full Text] [Related]
55. Transient perfusion in human melanoma xenografts.
Tufto I; Rofstad EK
Br J Cancer; 1995 Apr; 71(4):789-93. PubMed ID: 7536022
[TBL] [Abstract][Full Text] [Related]
56. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Taghian A; Lespinasse F; Guichard ME
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
[TBL] [Abstract][Full Text] [Related]
57. Variability in blood flow and pO2 in tumors in response to carbogen breathing.
Lanzen JL; Braun RD; Ong AL; Dewhirst MW
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):855-9. PubMed ID: 9845110
[TBL] [Abstract][Full Text] [Related]
58. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
Kaanders JH; Pop LA; Marres HA; van der Maazen RW; van der Kogel AJ; van Daal WA
Radiother Oncol; 1995 Dec; 37(3):190-8. PubMed ID: 8746587
[TBL] [Abstract][Full Text] [Related]
59. Radiotoxicity on bone marrow after 89Sr therapy radiosensitized by nicotinamide and carbogen in mice.
Zhang Y; Zheng X; Li T; Guo Y; Hang R; Lin J; Gu W
Nucl Med Commun; 2004 Jul; 25(7):701-4. PubMed ID: 15208497
[TBL] [Abstract][Full Text] [Related]
60. Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent manner.
Peters CE; Chaplin DJ; Hirst DG
Br J Radiol; 1997 Feb; 70():160-7. PubMed ID: 9135442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
